Complex sentence: Nilotinib, in the form of the hydrochloride monohydrate salt, is a tyrosine kinase inhibitor approved as Tasigna in the USA and the EU for drug-resistant chronic myelogenous leukemia (CML) Novartis 29/10/2007 Press Release.
Split into simpler sentences: Nilotinib, in the form of the hydrochloride monohydrate salt, is a tyrosine kinase inhibitor. It was approved as Tasigna in the USA and the EU for drug-resistant chronic myelogenous leukemia (CML) Novartis 29/10/2007 Press Release.